HOPKINTON, Mass., March 7 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that Ken Rice, Executive Vice...
HOPKINTON, Mass., Feb. 13 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that on February 8, 2007, it...
HOPKINTON, Mass., Feb. 7 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that Peter Savas, Chairman and Chief...
HOPKINTON, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI), a biotechnology company focused on diagnostic and...
HOPKINTON, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) announced today that it will be a major sponsor of...
Interim Results Report Drug's Safety and Possible Recovery of Function After Debilitating Injury; FDA "Orphan Drug" Status Provides Important...
HOPKINTON, Mass., Dec. 13 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that the Company will webcast the...
HOPKINTON, Mass., Nov. 6 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that Ken Rice, Executive Vice...
HOPKINTON, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced on October 26, 2006 it issued an...
HOPKINTON, Mass., Oct. 31 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that Peter Savas, Chairman and...
HOPKINTON, Oct. 30 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that Ken Rice, Executive Vice President...
HOPKINTON, Mass., Sept. 25 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today reported statistically significant results...
HOPKINTON, Mass., Aug. 30 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI), a biotechnology company focused on diagnostic and...
Methods Encompass Current Imaging Techniques Using Labeled Dopamine Transporter Binding Compounds HOPKINTON, Mass., Aug. 10...
HOPKINTON, Mass., July 27 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSI) today announced that it has appointed William L.S...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.